Osborne Clarke (OC) has returned to double-digit revenue growth for the 2017-18 financial year, with international revenues rising 14% to €273m (£240m).

In 2016-17 the firm saw revenues creep up 3.7%, after a year that UK managing partner Ray Berg (pictured) described as "challenging", given the uncertainty around Brexit.

However, 2017-18 has proved more successful, with the 14% revenue hike echoing three consecutive years of double-digit growth from 2013-14 to in 2015-16.

Non-UK revenues accounted for 42% of total turnover, with UK revenues rising 15% to £139.3m, while UK profit per equity partner increased by 11% to £711,000, up from £642,000 last year.

The firm's UK net profit rose by 17% to £61.2m, up from £52.5m last year.

International CEO Simon Beswick said: "There is caution towards Brexit but at the moment, the market we're practising in seems to be pretty resilient. Internationally, if you exclude the UK, there is no reason why the current level of growth ought to be impacted by Brexit, but you've got the broader US/China and EU trade wars, which could have an impact."

Berg added: "I think the UK is similar, but to an extent the indicators in the UK look stable for now. Everyone has that cautious view about what is around the corner, but I think we see the market continuing very much in same way.

"We've been focused on driving net profit, but we've not done that by reducing partners. We have more equity partners than last year."

An Osborne Clarke spokesperson commented: "As in previous strong years, we reward our people for their contribution to that performance with a share of our profits. In addition, we have a discretionary bonus scheme to reward exceptional contribution to our success. We prefer not to disclose specific figures."

During the year, the firm advised a number of what it described as "fast-growth companies" including Foresight, Barratt Homes, One Point, Wirecard, InfraRed and Ascential, while it joined the panel for the Department for Transport and was reappointed to the panels for the Pension Protection Fund and Vodafone.

Key mandates included advising European biopharmaceutical company TiGenix on its acquisition by Asia pharma giant Takeda in January, in a deal worth nearly £460m.

Beswick added: "We're very fortunate – a lot of these sectors are going through their own digital transformations and we are well placed to help. What's happening in the business world is playing into our sweetspot."

During the year, the firm launched in Sweden and also moved into mainland China via a tie-up with Shanghai firm Zhang Yu & Partners.